Connor, Clark & Lunn Investment Management (CC&L)’s Arcus Biosciences RCUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-64,043
| Closed | -$954K | – | 1570 |
|
|
2024
Q4 | $954K | Buy |
+64,043
| New | +$954K | ﹤0.01% | 947 |
|
|
2022
Q2 | – | Sell |
-212,743
| Closed | -$6.71M | – | 1177 |
|
|
2022
Q1 | $6.71M | Sell |
212,743
-53,800
| -20% | -$1.7M | 0.03% | 279 |
|
|
2021
Q4 | $10.8M | Sell |
266,543
-6,064
| -2% | -$245K | 0.05% | 230 |
|
|
2021
Q3 | $9.51M | Buy |
272,607
+3,896
| +1% | +$136K | 0.05% | 253 |
|
|
2021
Q2 | $7.38M | Buy |
268,711
+49,586
| +23% | +$1.36M | 0.04% | 282 |
|
|
2021
Q1 | $6.15M | Buy |
219,125
+24,586
| +13% | +$690K | 0.03% | 316 |
|
|
2020
Q4 | $5.05M | Buy |
194,539
+108,525
| +126% | +$2.82M | 0.03% | 336 |
|
|
2020
Q3 | $1.47M | Buy |
+86,014
| New | +$1.47M | 0.01% | 539 |
|